VBI Vaccines directors resign
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
VBI Vaccines Inc. said Steven Rubin and Adam Logal resigned as board members, effective Oct. 18.
Their resignations were not due to any disagreement with VBI, the biopharmaceutical
Cambridge, Mass.-based VBI develops and sells vaccines for infectious disease and immuno-oncology in Israel and internationally.
